Clinical Trial Update: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial comparing insulin degludec/liraglutide combination versus insulin glargine in adults with type 2 diabetes; completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• Insulin degludec/liraglutide (IDegLira) (insulin degludec/liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2017-01-20